BCM
ALXA

Bridgeway Capital Management’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Bridgeway Capital Management’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-50,000
Closed -$117K – 1546
2014
Q3 		$117K Hold
50,000
– – ﹤0.01% 1411
2014
Q2 		$229K Hold
50,000
– – 0.01% 1312
2014
Q1 		$222K Hold
50,000
– – 0.01% 1301
2013
Q4 		$237K Hold
50,000
– – 0.01% 1271
2013
Q3 		$256K Buy
+50,000
New +$235K 0.01% 1257

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HHMI
Howard Hughes Medical Institute Chevy Chase, Maryland $416M AUM 13.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bridgeway Capital Management's ALXA Position: Q4 2014 in Review

Bridgeway Capital Management sold out of Alexza Pharmaceuticals Inc (ALXA) in Q4 2014, closing a stake of 50,000 shares — an estimated $117K sold.

Bridgeway Capital Management first reported a position in ALXA in Q3 2013 and held it in 5 quarters. The position peaked at $256K in Q3 2013. 31 funds tracked by Wall St. Rank hold ALXA as of Q4 2014.

  • Bridgeway Capital Management reported no remaining Alexza Pharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • Bridgeway Capital Management sold 50,000 Alexza Pharmaceuticals Inc shares in Q4 2014, an estimated $117K.
  • Bridgeway Capital Management first reported a position in Alexza Pharmaceuticals Inc in Q3 2013 and held it in 5 quarters.
  • Bridgeway Capital Management's Alexza Pharmaceuticals Inc position peaked at $256K in Q3 2013.
  • 31 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q4 2014.

Based on Bridgeway Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.